Shapiro C - Search Results

1

Intracavitary bleomycin for the control of malignant effusions.

Bitran JD, Brown C, Desser RK, Kozloff MF, Shapiro C, Billings AA. Bitran JD, et al. Among authors: shapiro c. J Surg Oncol. 1981;16(3):273-7. doi: 10.1002/jso.2930160312. J Surg Oncol. 1981. PMID: 6163930

2

Multimodality therapy of stage III adenocarcinoma of the breast.

Bitran JD, Desser RK, Schifeling D, Shapiro CM, Kozloff MF, Robin E, Recant W, Michel A, Rochman H, Billings AA. Bitran JD, et al. Among authors: shapiro cm. J Surg Oncol. 1983 Jan;22(1):5-8. doi: 10.1002/jso.2930220103. J Surg Oncol. 1983. PMID: 6687399

3

Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast.

Shapiro CM, Schifeling D, Bitran JD, Desser RK, Rochman H, Michel A, Shapiro R, Evans R, Kozloff MF, Recant W, Billings AA. Shapiro CM, et al. Among authors: shapiro r. J Surg Oncol. 1982 Feb;19(2):119-21. doi: 10.1002/jso.2930190216. J Surg Oncol. 1982. PMID: 7057648

4

Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).

Bitran JD, Desser RK, Kozloff MF, Billings AA, Shapiro CM. Bitran JD, et al. Among authors: shapiro cm. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2049-51. Cancer Treat Rep. 1979. PMID: 393388 Clinical Trial.

5

Acute nephrotoxicity following cis-dichlorodiammine-platinum.

Bitran JD, Desser RK, Billings AA, Kozloff MF, Shapiro CM. Bitran JD, et al. Among authors: shapiro cm. Cancer. 1982 May 1;49(9):1784-8. doi: 10.1002/1097-0142(19820501)49:9<1784::aid-cncr2820490909>3.0.co;2-6. Cancer. 1982. PMID: 7200396

6

Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.

Ashenhurst J, Bitran JD, Robin E, Desser RK, Shapiro C, Kozloff MF, Billings AA. Ashenhurst J, et al. Among authors: shapiro c. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):869-72. Cancer Treat Rep. 1981. PMID: 7273020

7

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.

Bitran JD, Desser RK, Shapiro CM, Michel A, Kozloff MF, Billings AA, Recent W. Bitran JD, et al. Among authors: shapiro cm. Cancer. 1983 Feb 1;51(3):381-4. doi: 10.1002/1097-0142(19830201)51:3<381::aid-cncr2820510304>3.0.co;2-z. Cancer. 1983. PMID: 6821824

8

Survival of patients with lung cancer treated with vincristine and actinomycin D: An unsuccessful trial.

Bitran J, Billings A, Desser RK, Cohen L, Colman M, Shapiro C. Bitran J, et al. Among authors: shapiro c. Cancer. 1976 Apr;37(4):1669-72. doi: 10.1002/1097-0142(197604)37:4<1669::aid-cncr2820370409>3.0.co;2-n. Cancer. 1976. PMID: 1260683

9

Remission of metastatic adenocarcinoma of the colon.

Shapiro CM, Bitran JD, Shapiro RA. Shapiro CM, et al. Among authors: shapiro ra. JAMA. 1983 Nov 11;250(18):2503-4. JAMA. 1983. PMID: 6632141 No abstract available.

10

Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.

Bitran JD, Desser RK, DeMeester T, Shapiro CM, Billings A, Rubenstein L, Evans R, Colman M, Rao CY, Griem M, Golomb HM. Bitran JD, et al. Among authors: shapiro cm. Cancer Treat Rep. 1978 Mar;62(3):327-32. Cancer Treat Rep. 1978. PMID: 348305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

838 results

Search Page

Filters